27 Feb 2013 08:39
27 February 2013
Akers Biosciences, Inc.
("ABI" or the "Company")
French Certification for Disposable Breath Alcohol Detectors Received
ABI, a leading designer and manufacturer of rapid diagnostic screening and testing products, is pleased to announce that further to the Company's announcement on 19 February 2013, ABI's proprietary disposable breath alcohol detectors have been granted the final award of the NF Marque ("NF Mark") number 18/01. The NF Mark enables the breathalysers be marketed and sold to consumers in and around France under the brand name CHUBE by ABI's UK based partner (en)10 (Global) Limited. This follows the Company's breath alcohol detector being deemed in compliance with the quality criteria defined in French Standard NF X 20-702 for disposable breathalysers by the national reference laboratory of France, Laboratoire National de Métrologie et d'Essais under Certificate 25024.
Thomas A. Nicolette, Chief Executive Officer of ABI, commented: "We are honored that our detector has been certified against the French Standard and are delighted that it now bears the prestigious NF Mark. Over the last ten months (en)10 and ABI have collaborated to develop a specific product for the French market that offers 100% accuracy and reliability. Inappropriate alcohol consumption isn't just a problem on the roads, it's a major public health issue worldwide. The current breathalyzer law in France is an opportunity to bring fresh thinking and a new product to the market that can help consumers to improved well-being by encouraging sustainable changes in their attitudes to alcohol consumption. Using CHUBE, with proven change programmes and modern consumer marketing, means a highly precise disposable, single use device is now available to the French consumer at a low enough price to encourage repeat use"
Enquiries:
Thomas A. Nicolette
President and CEO
Tel. +1 856 848 8698
Antony Legge or James Thomas
Daniel Stewart & Company plc (Nomad and Broker)
Tel. +44 (0)20 7776 6550
About Akers Biosciences, Inc
Akers Biosciences develops, manufactures, and supplies rapid, point-of-care screening and testing products designed to bring health status information, both rapidly and directly, to the consumer or healthcare provider. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of several proprietary platform technologies. The Company's state-of-the-art rapid diagnostic assays can be performed virtually anywhere, in minutes, since time is always of essence. ABI is aligned with high volume medical product distributors to help facilitate the Company's growth into a major, worldwide competitor in the field of rapid diagnostics. Additional information on the Company and its products can be found at www.akersbiosciences.com
About (en)10 (Global) Ltd
Combining leading science innovations and clever design, (en)10 provides people the means to affect simple, precise, low-cost alcohol screening and the thinking, programmes and products to encourage broader, positive changes in attitudes to responsible alcohol consumption. It provides a fresh approach to achieving a healthy work culture and a more productive business: cutting costs and improving lives. Additional information on the Company and its products can be found at www.en-10.com and at www.soyezchube.com